Table 5.
Parameter | OS |
DFS |
---|---|---|
p value* | p value* | |
Gender | 0.761 | 0.738 |
Males | ||
Females | ||
Variant of UC | 0.409 | 0.449 |
Conventional | ||
Sarcomatoid | ||
Differentiation of UC** | 0.453 | 0.367 |
Squamous | ||
Absent | ||
Pattern of tumor invasion | ||
Nodular pattern | 0.463 | 0.644 |
Present | ||
Absent | ||
Trabecular pattern | 0.695 | 0.837 |
Present | ||
Absent | ||
Infiltrative pattern | 0.158 | 0.223 |
Present | ||
Absent | ||
Bilharziasis | 0.285 | 0.270 |
Present | ||
Absent | ||
Necrosis | 0.509 | 0.194 |
Present | ||
Absent | ||
PNI | 0.624 | 0.766 |
Present | ||
Absent | ||
LVI | 0.060 | 0.548 |
Present | ||
Absent | ||
pT stage | 0.050 | 0.449 |
T2a | ||
T2b | ||
T3a | ||
T3b | ||
T4a | ||
pN stage | 0.050 | 0.633 |
N0 | ||
N1 | ||
N2 | ||
M stage | 0.011 | Not Done *** |
M0 | ||
M1b | ||
Stage grouping | 0.018 | 0.800 **** |
II | ||
Stage grouping | 0.018 | 0.800 **** |
IIIA | ||
IIIB | ||
IVB | ||
c-Myc nuclear expression | 0.161 | 0.272 |
High (>120) | ||
Low (≤120) |
LVI, lymphovascular invasion; PNI, perineural invasion; UC, urothelial carcinoma; * p value by Log Rank test; ** Glandular group was excluded from analysis as they were only 2 cases; *** Not Done as the patients with M1b stage developed metastasis at the time of operation (i.e. had no disease free survival period), so no comparison analysis could be performed; **** Comparison was done between stages II, IIIA and IIIB. IVB did not included.